Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2019 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640619840211
Abstract: Background The relationship between vedolizumab trough levels and combined endoscopic and clinical remission is unknown. Objective To compare vedolizumab trough levels in patients with and without combined remission within the first year of treatment. Methods… read more here.
Keywords: combined endoscopic; trough levels; remission; clinical remission ... See more keywords
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2019 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640619873784
Abstract: Background Data from trials of vedolizumab for inflammatory bowel disease and from real-world studies suggest an exposure-response relationship, such that vedolizumab trough levels may predict clinical and endoscopic outcomes. Objective The purpose of this study… read more here.
Keywords: trough levels; vedolizumab; first year; inflammatory bowel ... See more keywords
Do Vedolizumab Trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11061553
Abstract: Background: Vedolizumab trough serum levels have been associated with clinical and endoscopic response in patients with inflammatory bowel disease (IBD). A recent study demonstrated that higher trough levels before dose escalation are associated with favorable… read more here.
Keywords: subsequent therapy; vedolizumab trough; trough levels; disease ... See more keywords